FyoniBio Gains CIR Accreditation to Support French Biopharma Companies
FyoniBio has been granted CIR (Crédit d’Impôt Recherche) accreditation through 2025, allowing its French partners to benefit from up to a 30% tax credit on R&D collaborations. With this recognition, FyoniBio strengthens its support for biopharmaceutical innovation in France—offering both scientific expertise and new financial advantages.
